Results 21 to 30 of about 28,908 (228)

Population pharmacokinetics of rituximab with or without plasmapheresis in kidney patients with antibody‐mediated disease

open access: yesBritish Journal of Clinical Pharmacology, 2013
International audienceAims Both rituximab and plasmapheresis can be associated in the treatment of immune‐mediated kidney diseases. The real impact of plasmapheresis on rituximab pharmacokinetics is unknown. The aim of this study was to compare rituximab
Florent Puisset   +2 more
exaly   +2 more sources

Use of plasmapheresis in women with placenta isufficiency after IVF

open access: yesRUDN Journal of Medicine, 2010
The effect of plasmapheresis is studied at placentary insufficiency at 120 women after IVF with placenta isufficiency. The age of investigated women was from 26 to 41 years, average 33,4 ± 4,6 years.
F B Buranova, O V Rogachevskiy
doaj   +1 more source

Plasmapheresis in Acute Hypertriglyceridemia-Induced Pancreatitis-The PHIP-JuGa-Study. [PDF]

open access: yesUnited European Gastroenterol J
Background and Aims The incidence of acute pancreatitis is increasing in the Western world. About 10% of cases are caused by hypertriglyceridemia.
Staudacher JJ   +24 more
europepmc   +2 more sources

Investigation and analysis of characteristics and mobility of the overlapping population of voluntary blood donation and plasmapheresis donation

open access: yesZhongguo shuxue zazhi, 2023
Objective To analyze the characteristics and mobility of the overlapping population of voluntary blood donation and plasmapheresis donation, so as to provide a scientific basis for the formulation of recruitment and retention strategies for blood ...
Wan LI   +10 more
doaj   +1 more source

Analysis of the impact of setting up plasmapheresis station on the collection volume of voluntary blood donation based on panel vector autoregressive model

open access: yesZhongguo shuxue zazhi, 2023
Objective To analyze the dynamic relationship between the setting up of plasmapheresis station and the volume of voluntary blood donation collected using panel vector autoregressive model, so as to provide scientific reference for the management policies
Wan LI   +9 more
doaj   +1 more source

The risks of low hemoglobin deferral in a large retrospective cohort of plasmapheresis donors and the influence factors of return for a subsequent donation in China [PDF]

open access: yesPeerJ, 2023
Background According to the Technical Operation Procedures for Plasmapheresis Collection Station (2019) in China, plasmapheresis donors with low hemoglobin (Hb) levels (men
Guanglin Xiao   +7 more
doaj   +2 more sources

Use of plasmapheresis in women with placenta insufficiency after IVF

open access: yesRUDN Journal of Medicine, 2010
The effect of plasmapheresis is studied at placentary insufficiency at 60 women after IVF with placenta isufficiency. The age of investigated women was from 26 to 42 years, average 34,6 ± 4,2 years.
F B Buranova
doaj   +1 more source

Demographic difference and influencing factors of motivations between whole blood and plasmapheresis donors: a comparative study

open access: yesZhongguo shuxue zazhi, 2023
Objective To explore the difference of demographics and influencing factors of motivations between whole blood donors and plasmapheresis donors, so as to provide scientific reference for effective recruitment strategy.
Guanglin XIAO   +7 more
doaj   +1 more source

Plasmapheresis in the ICU

open access: yesMedicina, 2023
Therapeutic plasma exchange (TPE) is a treatment paradigm used to remove harmful molecules from the body. In short, it is a technique that employs a process that functions partially outside the body and involves the replacement of the patient’s plasma.
Guleid Hussein   +6 more
openaire   +3 more sources

Therapeutic Plasmapheresis: Seven Year Experience of an Intensive Care Unit in Portugal

open access: yesActa Médica Portuguesa, 2022
Introduction: Therapeutic plasmapheresis is a therapeutic procedure in which the patient’s blood is passed through a medical device which separates out plasma from other components of blood. The plasma is removed and replaced with a replacement solution.
Rita Faria   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy